Virtual FDA Advisory Committee Meeting to Review New Drug Application for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder Tentatively Scheduled for Oct. 9, 2020 - BioSpace
Submitted by Anonymous (not verified) on Fri, 08/21/2020 - 11:31
